Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CL^pro inhibitors: theoretical justification in light of experimental evidences

References

• N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, and P. Niu, A novel coronavirus from patients with pneumonia in China 2019, N. Engl. J. Med. 382 (2020), pp. 727–733. doi:10.1056/NEJMoa2001017.
   PubMed Web of Science ®Google Scholar
• C. Wang, P.W. Horby, F.G. Hayden, and G.F. Gao, A novel coronavirus outbreak of global health concern, Lancet 395 (2020), pp. 470–743. doi:10.1016/S0140-6736(20)30185-9.
   PubMed Web of Science ®Google Scholar
• F. Wu, S. Zhao, B. Yu, Y.M. Chen, W. Wang, Z.G. Song, Y. Hu, Z.W. Tao, J.H. Tian, Y.Y. Pei, and M.L. Yuan, A new coronavirus associated with human respiratory disease in China, Nature 579 (2020), pp. 265–269. doi:10.1038/s41586-020-2008-3.
   PubMed Web of Science ®Google Scholar
• S. Ullrich and C. Nitsche, The SARS-CoV-2 main protease as drug target, Bioorg. Med. Chem. Lett. 30 (2020), pp. 127377. doi:10.1016/j.bmcl.2020.127377.
   PubMed Web of Science ®Google Scholar
• N. Adhikari, S.A. Amin, and T. Jha, Dissecting the drug development strategies against SARS-CoV-2 through diverse computational modeling techniques, in Methods in Pharmacology and Toxicology, K. Roy, ed., Springer, New York, 2020, pp. 1–103. doi:10.1007/7653_2020_46.
   Google Scholar
• I. Chakraborty and P. Maity, COVID-19 outbreak: Migration, effects on society, global environment and prevention, Sci. Tot. Environ. 22 (2020), pp. 138882. doi:10.1016/j.scitotenv.2020.138882.
   Google Scholar
• (2021). Available at https://www.worldometers.info/coronavirus/.
   Google Scholar
• A. Wilder-Smith and D.O. Freedman, Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak, J. Travel. Med. 27 (2020), pp. taaa020. doi:10.1093/jtm/taaa020.
   PubMed Web of Science ®Google Scholar
• V. Khosrawipour, H. Lau, T. Khosrawipour, P. Kocbach, H. Ichii, H. Ichii, J. Bania, and A. Mikolajczyk, Failure in initial stage containment of global COVID-19 epicenters, J. Med. Virol. 92 (2020), pp. 863–867. doi:10.1002/jmv.25883.
   PubMed Web of Science ®Google Scholar
• V.G. Da Costa, M.L. Moreli, and M.V. Saivish, The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century, Arch. Virol. 165 (2020), pp. 1517–1526. doi:10.1007/s00705-020-04628-0.
   PubMed Web of Science ®Google Scholar
• Y. Yang, F. Peng, R. Wang, K. Guan, T. Jiang, G. Xu, J. Sun, and C. Chang, The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China, J. Autoimmun. 109 (2020), pp. 102434. doi:10.1016/j.jaut.2020.102434.
   PubMed Web of Science ®Google Scholar
• Z. Song, Y. Xu, L. Bao, L. Zhang, P. Yu, Y. Qu, H. Zhu, W. Zhao, Y. Han, and C. Qin, From SARS to MERS: Thrusting coronaviruses into the spotlight, Viruses 11 (2019), pp. 59. doi:10.3390/v11010059.
   PubMed Web of Science ®Google Scholar
• A.E. Gorbalenya, S.C. Baker, R.S. Baric, R.J. Groot, C. Drosten, A.A. Gulyaeva, B.L. Haagmans, C. Lauber, A.M. Leontovich, B.W. Neuman, and D. Penzar, The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol. 5 (2020), pp. 536–544.
   PubMed Web of Science ®Google Scholar
• D.E. Gordon, G.M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K.M. White, M.J. O’Meara, V.V. Rezelj, J.Z. Guo, D.L. Swaney, and T.A. Tummino, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, Nature 583 (2020), pp. 459–468. doi:10.1038/s41586-020-2286-9.
   PubMed Web of Science ®Google Scholar
• Y. Chen, Q. Liu, and D. Guo, Emerging coronaviruses: Genome structure, replication, and pathogenesis, J. Med. Virol. 92 (2020), pp. 418–423. doi:10.1002/jmv.25681.
   PubMed Web of Science ®Google Scholar
• R.A. Khailany, M. Safdar, and M. Ozaslan, Genomic characterization of a novel SARS-CoV- 2, Gene. Rep. 19 (2020), pp. 100682. doi:10.1016/j.genrep.2020.100682.
   PubMed Web of Science ®Google Scholar
• H. Yang, M. Yang, Y. Ding, Y. Liu, Z. Lou, Z. Zhou, L. Sun, L. Mo, S. Ye, H. Pang, and G.F. Gao, The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor, Proc. Natl. Acad. Sci. 100 (2003), pp. 13190–13195. doi:10.1073/pnas.1835675100.
   PubMed Web of Science ®Google Scholar
• C. Wu, Y. Liu, Y. Yang, P. Zhang, W. Zhong, Y. Wang, Q. Wang, Y. Xu, M. Li, X. Li, and M. Zheng, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta. Pharm. Sinica B 10 (2020), pp. 766–788. doi:10.1016/j.apsb.2020.02.008.
   PubMed Web of Science ®Google Scholar
• A. Zumla, J.F. Chan, E.I. Azhar, D.S. Hui, and K.Y. Yuen, Coronaviruses – drug discovery and therapeutic options, Nat. Rev. Drug Discov. 15 (2016), pp. 327–347.
   PubMed Web of Science ®Google Scholar
• K. Anand, J. Ziebuhr, P. Wadhwani, J.R. Mesters, and R. Hilgenfeld, Coronavirus main protease (3CLpro) structure: Basis for design of anti-SARS drugs, Science 300 (2003), pp. 1763–1767. doi:10.1126/science.1085658.
   PubMed Web of Science ®Google Scholar
• A. Sternberg, D.L. McKee, and C. Naujokat, Novel drugs targeting the SARS-CoV-2/COVID-19 machinery, Curr. Top. Med. Chem. 20 (2020), pp. 1–11. doi:10.2174/1568026620999200517043137.
   Web of Science ®Google Scholar
• N. Adhikari, S.K. Baidya, A. Saha, and T. Jha, Structural insight into the viral 3C-like protease inhibitors: Comparative SAR/QSAR approaches, in Viral Proteases and Their Inhibitors, S.P. Gupta, ed., Academic Press, London, 2017, pp. 317–409.
   Google Scholar
• M. Stoermer, Homology models of coronavirus 2019-nCoV 3CLpro protease, Chemrxiv 11637294 (2020), 530 pp. v3. doi:10.26434/chemrxiv.11637294.v3.
   Google Scholar
• T. Zhang, Q. Wu, and Z. Zhang, Probable pangolin origin of SARS-CoV-2 Associated with the COVID-19 outbreak, Curr. Biol. 30 (2020), pp. 1346–1351. doi:10.1016/j.cub.2020.03.022.
   PubMed Web of Science ®Google Scholar
• A.A. Rabaan, S.H. Al-Ahmed, S. Haque, R. Sah, R. Tiwari, Y.S. Malik, K. Dhama, M.I. Yatoo, D.K. Bonilla-Aldana, and A.J. Rodriguez-Morales, SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview, InfezMed 28 (2020), pp. 174–184.
   PubMedGoogle Scholar
• M.M. Hatmal, W. Alshaer, M.A.I. Al-Hatamleh, M. Hatmal, O. Smadi, M.O. Taha, A.J. Oweida, J.C. Boer, R. Mohamud, and M. Plebanski, Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2, Cells 9 (2020), pp. 2638. doi:10.3390/cells9122638.
   Web of Science ®Google Scholar
• M. Kandeel and M. Al-Nazawi, Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease, Life Sci. 251 (2020), pp. 117627. doi:10.1016/j.lfs.2020.117627.
   PubMed Web of Science ®Google Scholar
• A.B. Gurung, M.A. Ali, J. Lee, M.A. Farah, and K.M. Al-Anazi, Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M pro enzyme through in silico approach, Life Sci. 255 (2020), pp. 117831. doi:10.1016/j.lfs.2020.117831.
   PubMed Web of Science ®Google Scholar
• A.A. Elfiky, Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study, Life Sci. 253 (2020), pp. 117592. doi:10.1016/j.lfs.2020.117592.
   PubMed Web of Science ®Google Scholar
• M.T. Qamar, S.M. Alqahtani, M.A. Alamri, and L.L. Chen, Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants, J. Pharm. Anal. 10 (2020), pp. 313–319. doi:10.1016/j.jpha.2020.03.009.
   PubMed Web of Science ®Google Scholar
• Q. Li and C. Kang, Progress in developing inhibitors of SARS-CoV-2 3C-like protease, Microorganisms 8 (2020), pp. 1250. doi:10.3390/microorganisms8081250.
   PubMed Web of Science ®Google Scholar
• S.A. Amin, S. Banerjee, K. Ghosh, S. Gayen, and T. Jha, Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors, Bioorg. Med. Chem. 29 (2020), pp. 115860. doi:10.1016/j.bmc.2020.115860.
   PubMedGoogle Scholar
• S.A. Amin and T. Jha, Fight against novel coronavirus: A perspective of medicinal chemists, Eur. J. Med. Chem. 201 (2020), pp. 112559. doi:10.1016/j.ejmech.2020.112559.
   PubMed Web of Science ®Google Scholar
• S.A. Amin, S. Banerjee, S. Gayen, and T. Jha, Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors? Eur. J. Med. Chem. 215 (2021), pp. 113294. doi:10.1016/j.ejmech.2021.113294.
   PubMed Web of Science ®Google Scholar
• H.C. Hung, Y.Y. Ke, S.Y. Huang, P.N. Huang, Y.A. Kung, T.Y. Chang, K.J. Yen, T.T. Peng, S.E. Chang, C.T. Huang, and Y.R. Tsai, Discovery of M protease inhibitors encoded by SARS-CoV-2, Antimicrob. Agents Chemother. 64 (2020), pp. e00872–20. doi:10.1128/AAC.00872-20.
   PubMed Web of Science ®Google Scholar
• L. Zhang, D. Lin, Y. Kusov, Y. Nian, Q. Ma, J. Wang, A. Von Brunn, P. Leyssen, K. Lanko, J. Neyts, and A. De Wilde, α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment, J. Med. Chem. 63 (2020), pp. 4562–4578. doi:10.1021/acs.jmedchem.9b01828.
   PubMed Web of Science ®Google Scholar
• L. Zhang, D. Lin, X. Sun, U. Curth, C. Drosten, L. Sauerhering, S. Becker, K. Rox, and R. Hilgenfeld, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 368 (2020), pp. 409–412. doi:10.1126/science.abb3405.
   PubMed Web of Science ®Google Scholar
• K. Roy, S. Kar, and R.N. Das, A Primer on QSAR/QSPR Modeling: Fundamental Concepts, Springer, New York, 2015.
   Google Scholar
• S. Chtita, A. Belhassan, M. Bakhouch, A.I. Taourati, A. Aouidate, S. Belaidi, M. Moutaabbid, S. Belaaouad, M. Bouachrine, and T. Lakhlifi, QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods, Chemom. Intell. Lab. Syst. 210 (2021), pp. 104266. doi:10.1016/j.chemolab.2021.104266.
   PubMed Web of Science ®Google Scholar
• V.M. Alves, T. Bobrowski, C.C. Melo-Filho, D. Korn, S. Auerbach, C. Schmitt, E.N. Muratov, and A. Tropsha, QSAR Modeling of SARS-CoV Mpro inhibitors identifies sufugolix, cenicriviroc, proglumetacin, and other drugs as candidates for repurposing against SARS-CoV-2, Mol. Inf. 40 (2021), pp. e2000113. doi:10.1002/minf.202000113.
   PubMed Web of Science ®Google Scholar
• V.H. Masand, V. Rastija, M.K. Patil, A. Gandhi, and A. Chapolikar, Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modeling, SAR QSAR Environ. Res. 31 (2020), pp. 643–654. doi:10.1080/1062936X.2020.1784271.
   PubMed Web of Science ®Google Scholar
• V.H. Masand, S. Akasapu, A. Gandhi, V. Rastija, and M.K. Patil, Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study, Chemom. Intell. Lab. Syst. 206 (2020), pp. 104172. doi:10.1016/j.chemolab.2020.104172.
   PubMed Web of Science ®Google Scholar
• V. Kumar and K. Roy, Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases, SAR QSAR Environ. Res. 31 (2020), pp. 511–526. doi:10.1080/1062936X.2020.1776388.
   PubMed Web of Science ®Google Scholar
• K. Ghosh, S.A. Amin, S. Gayen, and T. Jha, Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors, J. Mol. Struct. 1224 (2020), pp. 129026. doi:10.1016/j.molstruc.2020.129026.
   PubMed Web of Science ®Google Scholar
• S.A. Amin, K. Ghosh, S. Gayen, and T. Jha, Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors, J. Biomol. Struct. Dyn. In Press (2020), pp. 1–10. doi:10.1080/07391102.2020.1780946
   Web of Science ®Google Scholar
• S.A. Amin, S. Banerjee, S. Singh, I.A. Qureshi, S. Gayen, and T. Jha, First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: An endeavor on COVID-19 drug discovery, Mol. Divers. In press (2020). doi:10.1007/s11030-020-10166-3
   Web of Science ®Google Scholar
• S.A. Amin, K. Ghosh, S. Singh, I.A. Qureshi, T. Jha, and S. Gayen, Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery, Mol. Divers. (2021). doi:10.1007/s11030-021-10198-3.
   Web of Science ®Google Scholar
• C. Ma, M.D. Sacco, B. Hurst, J.A. Townsend, Y. Hu, T. Szeto, X. Zhang, B. Tarbet, M.T. Marty, Y. Chen, and J. Wang, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease, bioRxiv 30 (2020), pp. 678–692.
   Google Scholar
• Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, C. Peng, and Y. Duan, Structure of M pro from SARS-CoV-2 and discovery of its inhibitors, Nature 582 (2020), pp. 289–293. doi:10.1038/s41586-020-2223-y.
   PubMed Web of Science ®Google Scholar
• M.D. Sacco, C. Ma, P. Lagarias, A. Gao, J.A. Townsend, X. Meng, P. Dube, X. Zhang, Y. Hu, N. Kitamura, and B. Hurst, Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M pro and cathepsin L, Sci. Adv. 6 (2020), pp. eabe0751. doi:10.1126/sciadv.abe0751.
   PubMed Web of Science ®Google Scholar
• W. Dai, B. Zhang, X.M. Jiang, H. Su, J. Li, Y. Zhao, X. Xie, Z. Jin, J. Peng, F. Liu, and C. Li, Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 368 (2020), pp. 1331–1335. doi:10.1126/science.abb4489.
   PubMed Web of Science ®Google Scholar
• W. Vuong, M.B. Khan, C. Fischer, E. Arutyunova, T. Lamer, J. Shields, H.A. Saffran, R.T. McKay, M.J. Van Belkum, M. Joyce, and H.S. Young, Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication, Nat. Commun. 11 (2020), pp. 4282. doi:10.1038/s41467-020-18096-2.
   PubMed Web of Science ®Google Scholar
• A.D. Rathnayake, J. Zheng, Y. Kim, K.D. Perera, S. Mackin, D.K. Meyerholz, M.M. Kashipathy, K.P. Battaile, S. Lovell, S. Perlman, and W.C. Groutas, 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice, Sci. Transl. Med. 12 (2020), pp. eabc5332. doi:10.1126/scitranslmed.abc5332.
   PubMed Web of Science ®Google Scholar
• W. Zhu, M. Xu, C.Z. Chen, H. Guo, M. Shen, X. Hu, P. Shinn, C. Klumpp-Thomas, S.G. Michael, and W. Zheng, Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening, ACS Pharmacol. Transl. Sci. 3 (2020), pp. 1008–1016. doi:10.1021/acsptsci.0c00108.
   PubMedGoogle Scholar
• H. Su, S. Yao, W. Zhao, M. Li, J. Liu, W. Shang, H. Xie, C. Ke, M. Gao, K. Yu, and H. Liu, Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro, bioRxiv (2020). doi:10.1101/2020.04.13.038687.
   Google Scholar
• Discovery Studio 3.0. Accelrys Inc., San Diego, USA 2011. Available at http://www.accelrys.com.
   Google Scholar
• C.W. Yap, PaDEL descriptor: An open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem. 32 (2011), pp. 1466–1474. doi:10.1002/jcc.21707.
   PubMed Web of Science ®Google Scholar
• The simple, user-friendly and reliable online standalone tools freely. Available at http://teqip.jdvu.ac.in/QSAR_Tools/.
   Google Scholar
• Statistica 7.1, StatSoft Inc. 2300 East 14th Street Tulsa, OK 74104, United States.
   Google Scholar
• H. Yang, J. Li, Z. Wu, W. Li, G. Liu, and Y. Tang, Evaluation of different methods for identification of structural alerts using chemical Ames mutagenicity data set as a benchmark, Chem. Res. Toxicol. 30 (2017), pp. 1355–1364. doi:10.1021/acs.chemrestox.7b00083.
   PubMed Web of Science ®Google Scholar
• T. Ferrari, D. Cattaneo, G. Gini, N.G. Bakhtyari, A. Manganaro, and E. Benfenati, Automatic knowledge extraction from chemical structures: The case of mutagenicity prediction, SAR QSAR Environ. Res. 24 (2013), pp. 365–383. doi:10.1080/1062936X.2013.773376.
   PubMed Web of Science ®Google Scholar
• L. Chen, Y. Li, Q. Zhao, H. Peng, and T. Hou, ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques, Mol. Pharm. 8 (2011), pp. 889–900. doi:10.1021/mp100465q.
   PubMed Web of Science ®Google Scholar
• S. Banerjee, S.A. Amin, N. Adhikari, and T. Jha, Essential elements regulating HDAC8 inhibition: A classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors, J. Biomol. Struct. Dyn. 38 (2020), pp. 5513–5525. doi:10.1080/07391102.2019.1704881.
   PubMed Web of Science ®Google Scholar
• N. Adhikari, A.K. Halder, A. Saha, K.D. Saha, and T. Jha, Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studies, Toxicol. In Vitro 29 (2015), pp. 1392–1404. doi:10.1016/j.tiv.2015.05.017.
   PubMed Web of Science ®Google Scholar
• T. Fawcett, An introduction to ROC analysis, Pat. Recog. Let. 27 (2006), pp. 861–874. doi:10.1016/j.patrec.2005.10.010.
   Web of Science ®Google Scholar
• K. Roy and R.N. Das, QSTR with extended topochemical atom (ETA) indices. 16. Development of predictive classification and regression models for toxicity of ionic liquids towards Daphnia magna, J. Hazard. Mater. 254 (2013), pp. 166–178. doi:10.1016/j.jhazmat.2013.03.023.
   PubMed Web of Science ®Google Scholar
• A. Pérez-Garrido, A.M. Helguera, F. Borges, M.N. Cordeiro, V. Rivero, and A.G. Escudero, Two new parameters based on distances in a receiver operating characteristic chart for the selection of classification models, J. Chem. Inf. Model. 51 (2011), pp. 2746–2759. doi:10.1021/ci2003076.
   PubMed Web of Science ®Google Scholar
• A. Pérez-Garrido, A.M. Helguera, G.C. López, M.N. Cordeiro, and A.G. Escudero, A topological substructural molecular design approach for predicting mutagenesis end-points of α, β-unsaturated carbonyl compounds, Toxicology 268 (2010), pp. 64–77. doi:10.1016/j.tox.2009.11.023.
   PubMed Web of Science ®Google Scholar
• M.T. Ibrahim, A. Uzairu, S. Uba, and G.A. Shallangwa, Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors, Heliyon 6 (2020), pp. e03289. doi:10.1016/j.heliyon.2020.e03289.
   PubMed Web of Science ®Google Scholar
• B.A. Thurston and A.L. Ferguson, Machine learning and molecular design of self-assembling π-conjugated oligopeptides, Mol. Simul. 44 (2018), pp. 930–945. doi:10.1080/08927022.2018.1469754.
   Web of Science ®Google Scholar
• K. Roy and H. Kabir, QSPR with extended topochemical atom (ETA) indices: Modeling of critical micelle concentration of non-ionic surfactants, Chem. Eng. Sci. 73 (2012), pp. 86–98. doi:10.1016/j.ces.2012.01.005.
   Web of Science ®Google Scholar
• L.H. Hall and L.B. Kier, Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information, J. Chem. Inf. Comput. Sci. 35 (1995), pp. 1039–1045. doi:10.1021/ci00028a014.
   Google Scholar
• P. Gramatica, M. Corradi, and V. Consonni, Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors, Chemosphere 41 (2000), pp. 763–777. doi:10.1016/S0045-6535(99)00463-4.
   PubMed Web of Science ®Google Scholar
• K. Khan and K. Roy, Ecotoxicological modelling of cosmetics for aquatic organisms: A QSTR approach, SAR QSAR Environ. Res. 28 (2017), pp. 567–594. doi:10.1080/1062936X.2017.1352621.
   PubMed Web of Science ®Google Scholar
• K. Roy and G. Ghosh, QSTR with extended topochemical atom indices. 2. Fish toxicity of substituted benzenes, J. Chem. Inf. Comput. Sci. 44 (2004), pp. 559–567. doi:10.1021/ci0342066.
   PubMedGoogle Scholar
• K. Roy and R.N. Das, On some novel Extended Topochemical Atom (ETA) parameters for effective encoding of chemical information and modelling of fundamental physicochemical properties, SAR QSAR Environ. Res. 22 (2011), pp. 451–472. doi:10.1080/1062936X.2011.569900.
   PubMed Web of Science ®Google Scholar
• R. Todeschini and V. Consonni, Molecular Descriptors for Chemoinformatics Vol. I, John Wiley & Sons, New York, 2009.
   Google Scholar